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It is well established that mitochondrial disorders (MIDs) may phenotypically mimic motor neuron disease.1–3 These similarities fade 
with disease progression and the development of 
mitochondrial multiple organ dysfunction syndrome 
(MIMODS).4,5 However, if progression is slow and 
MIMODS is mild, a MID may still be misinterpreted 
as amyotrophic lateral sclerosis (ALS), as with the case 
presented below.
Case Report
A 48-year-old Caucasian male presented to the 
Neurological Hospital Rosenhügel, Vienna, Austria, in 
February 2001. The patient had first noticed occasional 
weakness of the left brachial biceps muscle at 36 years 
of age. Four years later, fasciculations occurred for the 
first time in the shoulder girdle muscles which spread 
bilaterally to other muscles and the lower limbs during 
the following years. By the age of 46 years, the patient’s 
muscle weakness had spread to the left intrinsic hand 
muscles, particularly those of the left thumb and fifth 
finger. The muscle weakness increased when it was 
cold and led to involuntary muscle contractions. He 
was an amateur cyclist, regularly cycling 4,000 km 
per year. After cycling, he often experienced aching 
of the neck extensor muscles which prevented him 
from sleeping. Previous creatine kinase values for the 
patient were unavailable. 
One year before presentation, the patient was 
diagnosed with ALS by a neurologist based on 
clinical and electrophysiological findings. There was 
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abstract: Similarities between a mitochondrial disorder (MID) and amyotrophic lateral sclerosis (ALS) fade 
with disease progression and the development of mitochondrial multiple organ dysfunction syndrome (MIMODS). 
However, with mild MIMODS, a MID may still be misinterpreted as ALS. We report a 48-year-old male who 
presented to the Neurological Hospital Rosenhügel, Vienna, Austria, in February 2001 with slowly progressive 
weakness, wasting and left upper limb fasciculations which spread to the shoulder girdle and lower limbs. 
Additionally, he developed tetraspasticity and bulbar involvement. He had been diagnosed with ALS a year 
previously due to electrophysiological investigations indicative of a chronic neurogenic lesion. However, a muscle 
biopsy revealed morphological features of a MID and a combined complex-II/III defect. Nerve conduction studies 
were performed over subsequent years until February 2011. This case demonstrates that MIDs may mimic ALS at 
onset and begin as a mono-organ disorder but develop into a multi-organ disease with long-term progression. A 
combined complex II/III defect may manifest with bulbar involvement.
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Phosphorylation; Case Report; Austria.
تقدم املر�ص، ومع ظهور  مع   )ALS( ال�شموري  والت�شلب اجل�نبي   )MID( املتقدرة  ا�شطراب�ت  الت�ش�به بني  تدريجي�  امللخ�ص: يختفي 
 ALS على اأنه MID املعتدلة، فقد ي�شخ�ص MIMODS غري اأنه يف ح�الت .)MIMODS( متالزمة االختالل املتعدد االأع�ش�ء املتقدري
عن طريق اخلط�أ. ونعر�ص هن� حل�لة رجل عمره 48 ع�م� يف م�شت�شفى روزنهيقل لالأمرا�ص الع�شبية يف مدينة فيينا ب�لنم�ش� يف فرباير 
من ع�م 2001م ك�ن ي�شكو من �شعف تدريجي، وهزال، وارجت�ف حزمي يف الطرف العلوي االأي�رض، امتد الحق� اإىل حزام الكتف واالأطراف 
ال�شفلى. ثم اأظهر املري�ص �شن�ج� رب�عي� مع اكتن�ف ب�شلي. وك�نت ح�لة املري�ص قد �شخ�شت قبل ع�م على اأنه� ALS بن�ء على فحو�ش�ت 
اأن خ�ش�ئ�ص مورفولوجية دلت على  اأو�شح  اأن فح�ص خزعة من الع�شل  اإال  اآفة مزمنة ع�شبية املن�ش�أ.  اأ�ش�رت اإىل  كهربية–فيزيولوجية 
االإ�ش�بة بـ MID، متزامنة مع عيب يف مركب – II/III. واأجريت درا�ش�ت حول النقل الع�شبي بعد �شنوات من الفحو�ش�ت ال�ش�بقة حتى ع�م 
2011م. تو�شح هذه احل�لة اإىل اأن ح�الت الـ MID قد حت�كي ALS يف بداية املر�ص، وتبداأ يف ع�شو واحد، ولكنه� تتطور اإىل اأن ت�شبح 
اختالال متدرج� يف عدد من االأع�ش�ء. وقد يحدث عيب يف مركب – II/III مع اكتن�ف ب�شلي.
مفتاح الكلمات: مر�ص الع�شبون احلركي؛ ا�شطراب�ت املتقدرة؛ الت�شلب اجل�نبي ال�شموري؛ احلم�ص الريبي النووي منزوع االأك�شجني؛ فسفرة ت�أك�شدية؛ 
تقرير ح�لة؛ النم�ش�.
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slight wasting of the shoulder girdle muscles and 
diffuse wasting of the left upper limb muscles with 
predominance of the left intrinsic hand muscles. 
Fasciculations were seen in all muscles of the left 
upper limb and the shoulder girdle, tendon reflexes 
were exaggerated and pyramidal signs were bilaterally 
positive. Cerebral magnetic resonance imaging 
(MRI) was normal and an MRI scan of the cervical 
spine showed only mild degenerative alterations. The 
diagnosis of ALS was confirmed by other neurologists. 
The patient was prescribed riluzole and high-dose 
vitamin D without effect. Immunoglobulins were 
prescribed without rationale or beneficial effect. 
Following the initiation of riluzole treatment, the 
patient developed muscle cramps in the distal lower 
limb muscles and his resting pulse occasionally 
reached 130 beats/minute. Although levothyroxine 
was prescribed by endocrinologists to prevent growth 
of diffuse multinodular goitres, the patient was non-
compliant with the treatment. 
At presentation to the Neurological Hospital 
Rosenhügel, the patient had developed liquid dysphagia 
and chewing difficulties. He had often complained of 
hyperhidrosis over the preceding years. Additionally, his 
history was positive for hyperlipidaemia and there was 
a family history of hypoacusis and gibbus deformity 
from his paternal grandfather. Re-examination of the 
patient revealed wasting of the tongue edges, frequent 
fasciculations of the tongue, distal weakness with left-
sided predominance, diffuse wasting, exaggerated 
tendon reflexes, positional tremors with left-sided 
predominance, fasciculations in all muscles and 
positive pyramidal signs for the upper limbs. With 
regards to the lower limbs, there was weakness of the 
left foot extensors (grade M5-), exaggerated tendon 
reflexes and bilateral positive pyramidal signs.
The results of multiple nerve conduction studies 
performed over the following years are shown in 
Table 1. Needle electromyography of the right brachial 
biceps muscle showed fibrillations and fasciculations 
with bizarre morphology at 20/20 sites, increased 
mean motor unit action potential duration, increased 
polyphasia and satellite potentials and a reduced 
interference pattern at maximal voluntary contractions. 
His creatine kinase levels were slightly elevated 
(maximal value: 97 U/L; normal value: <70 U/L) 
and he had hypercholesterolaemia. However, the 
results of a lactate stress test were normal. Transcranial 
magnetic stimulation revealed increased central motor 
conduction time (CMCT) of the C8 motor neuron on 
the right side, normal CMCT of the C8 motor neuron 
on the left side and normal CMCT of the S1 nerve root 
bilaterally. Ganglioside GM1 antibodies were normal. 
An abdominal ultrasound revealed a double kidney on 
the right side. 
Based on the patient’s history and the existence 
of atypical clinical features—including hyperhidrosis, 
goitre and hyperlipidaemia—MIMODS involving the 
central nervous system, the peripheral motor, sensory 
and vegetative nerves, the endocrine system and the 
skeletal muscles was suspected. A muscle biopsy 
from the lateral vastus muscle showed neurogenic 
features with grouped atrophic fibres and a fibre-
type grouping; however, the biopsy also showed 
indications for a MID, including a coarsening of the 
mitochondrial pattern on oxidative enzyme and 
Gomori trichrome stains. Immunohistochemistry 
revealed cytochrome c oxidase-hyporeactive/negative 
fibres and electron microscopy indicated the 
subsarcolemmal accumulation of abnormally-shaped 
mitochondria. Biochemical investigations of the muscle 
homogenate revealed a combined complex-II/III defect 
consisting of succinate cytochrome c-oxidoreductase 
related to non-collagen protein and citrate synthase. 
No tests for coenzyme-Q activity were carried out. 
Screening for common mitochondrial DNA (mtDNA) 
mutations causing the following conditions was non-
informative: mitochondrial encephalomyopathy, lactic 
acidosis and stroke-like episodes; myoclonic epilepsy 
with red-ragged fibres; chronic progressive external 
ophthalmoplegia; Leber hereditary optic neuro-
pathy; neuropathy, ataxia and retinitis pigmentosa; 
maternally-inherited Leigh syndrome; non-syndromic 
myopathy; cardiomyopathy; dementia; diabetes; 
or encephalopathy. Despite repeated attempts to 
contact the patient for further investigations, he was 
subsequently lost to follow-up.
Discussion
Misinterpretation of a MID as ALS may occur with 
mild or unnoticeable MIMODS or when the MID 
starts primarily with motor manifestations and 
spasticity due to additional cerebral involvement.4–6 
In the presented case, the implications of the thyroid 
dysfunction, hyperhidrosis, hyperlipidaemia and 
autonomic and sensory involvement were neglected. 
In order to avoid misdiagnosis, clinical manifestations 
should not be ignored and a common cause of 
seemingly unrelated manifestations should not be 
excluded. Under these circumstances, patients with 
suspected ALS should be investigated for a MID. 
Since most MIDs develop into MIMODS during the 
disease course, it is usually just a matter of time before 
MIMODS becomes evident.4,5 
Nevertheless, it is important to note that ALS may 
also show morphological evidence of a mitochondrial 
defect. Hirano et al. reported a 65-year-old ALS 
patient whose muscle biopsy showed 10% ragged-
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and alterations of the mitochondrial genome and 
transcriptome.8–14 There are also indications that 
mtDNA deletions are more common in individuals 
with sporadic ALS as compared to healthy controls.15 
Mitochondrial dysfunction in ALS is often regarded 
as secondary following the exposure of mtDNA to 
increased oxidative stress.16 
In the current case, the diagnosis of ALS was 
eventually excluded due to the long duration of 
red fibres and 3% cytochrome c oxidase-negative 
fibres.7 However, contrary to the present case, no 
biochemical abnormalities were detected.7 A number 
of other reports have described mitochondrial 
dysfunction in ALS, including decreased complex-I 
activity, decreased superoxide dismutase 1 function 
and energy production, increased apoptosis, abnormal 
calcium homeostasis, impaired axonal transport 
of mitochondria, respiratory chain dysfunction 
Table 1: Nerve conduction study results of a patient with a mitochondrial disorder mimicking amyotrophic lateral 
sclerosis at onset










dL in ms 4.8 NP 6.3 4.4 4.8 4.3 6.0 4.6 NP 6.3 5.9 NP
CMAP in mV 3.0 NP 0.9 4.2 1.8 4.6 0.8 3.2 NP 1.5 1.3 NP
NCV in m/s 48.0 NP 41/52* 49/51 52.0 59.0 41.0 56.0 NP 57.0 41.2 NP
Sensory
SNAP in μV 40.0 NP NP NP 28.8 15.5 55.0 40.0 NP 34.0 NP NP
NCV in m/s 56.0 NP NP NP 59.0 60.0 63.0 56.0 NP 50.0 NP NP
F-wave 
persistence





dL in ms 3.3 NP 3.8 3.2 2.3 3.4 3.8 3.3 4.2 4.0 NP NP
CMAP in mV 3.0 NP 2.8 3.2 6.2 8.3 2.7 2.9 0.9 1.9 NP NP
NCV in m/s 59/43* NP 56/45 53/58 62/51 43/41 60/33 47/53 48/38 46/28 NP NP
Sensory
SNAP in μV 20.0 NP 20.0 5.0 18.8 9.5 11.0 NP NP NP NP NP
NCV in m/s 61.0 NP 55.0 NP 51.0 54.0 48.0 NP NP 30.0 NP NP
F-wave 
persistence






dL in ms NP NP NP 5.5 4.5 4.0 4.5 5.1 4.8 NP NP NP
CMAP in mV NP NP NP 4.0 8.9 10.1 NP 3.0 3.0 NP NP NP





dL in ms NP NP NP NP 3.9 3.4 NP NP NP 4.8 NP NP
CMAP in mV NP NP NP NP 18.5 12.7 NP NP NP 6.8 NP NP





SNAP in μV NP NP NP 5.5 NP 6.1 2.0 6.0 NP NP NP NP
NCV in m/s NP NP NP 40.0 NP 42.0 43.0 38.0 NP NP NP NP
L = left; R = right; dL = distal latency; ms = milliseconds; CMAP = compound muscle action potential; mV = millivolt; NCV = nerve conduction 
velocity; m/s = metres per second; SNAP = sensory nerve action potential; μV = microvolts; NP = not performed. 
*Values represent the distal and proximal measurements.
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the clinical course, the multisystemic nature of the 
phenotype (MIMODS), the muscle biopsy findings, 
the normal cerebral MRI scan and the biochemical 
findings. The strongest arguments in favour of a 
diagnosis of a primary mitochondrial defect were the 
multi-organ phenotype and the presence of a complex 
II/III defect. On the other hand, the histochemical 
findings did not match the biochemical findings. Since 
no mtDNA mutations could be detected, the complex 
II/III defect may have instead been due to a mutation 
in a nuclear DNA-located gene rather than a mtDNA-
located gene. However, the precise genetic defect still 
requires confirmation. 
Another point of interest with regards to the 
current case is the late onset of the disease and its 
slow progression. The frequency and severity of MIDs 
are usually increased in children and the disease 
usually progresses slowly in adults.17,18 Often, only a 
single organ is initially affected and other organs are 
consecutively affected after long periods of time.19 
There is no consistent pattern of organ involvement 
and no regular sequence among the organs which 
are affected. Factors which drive the pattern of organ 
involvement and the speed of progression may include 
the type of mutation (e.g. protein, transfer/ribosomal 
ribonucleic acid, helicase or polymerase mutations) 
or modifying genes and the heteroplasmy rate or the 
threshold effect in the case of mtDNA mutations.20
Conclusion
This case suggests that a MID can mimic ALS at the 
onset of the disease and that it may start as a mono-
organ disorder and subsequently turn into a multi-
organ disease after slow progression over a prolonged 
period of time. The exclusion of ALS may indicate 
the presence of a MID and a complex II/III defect 
may manifest with bulbar involvement. Patients with 
apparent ALS should be investigated for a MID if 
atypical manifestations have been noted. 
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